XML 79 R54.htm IDEA: XBRL DOCUMENT v3.22.2
Shareholders' Equity (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
$ / shares
Jun. 30, 2020
USD ($)
$ / shares
Jun. 30, 2022
€ / shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2021
€ / shares
Jun. 30, 2021
USD ($)
$ / shares
shares
May 01, 2020
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Common Stock, Shares, Outstanding         26,112,322   26,035,910  
Share-based compensation expense | $ $ 49,766 $ 37,034 $ 34,874          
Issuance of ordinary shares due to share option exercises, Shares 0              
Share-based Payment Arrangement, Amount Capitalized | $ $ 1,221 $ 1,338 1,157          
Common Stock, Capital Shares Reserved for Future Issuance         1,480,926      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 250.00%              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number         5,298   5,298  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares $ 0              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ / shares         $ 80.01   $ 80.01  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares $ 0              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number         5,298      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ / shares         $ 80.01      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 2 years 9 months 18 days 3 years 9 months 18 days            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | $ $ 5,460 $ 2,280 $ 40,906          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares             $ 134.45  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 110.28              
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number             1,158,716  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (15,373)              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 0              
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | $ / shares $ 0              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares 0              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights               1,055,377
Class of Warrant or Right, Percentage of Securities               3.875%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares               $ 60
Warrants Not Settleable in Cash, Fair Value Disclosure | $         $ 22,432      
Common Stock, Value per Share | € / shares       € 0.01   € 0.01    
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $         89,977      
Restricted Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 80.26 $ 93.64 $ 46.94          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | $     $ 1,905   $ 10,123   $ 17,231  
Restricted share units [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares         $ 83.66   $ 93.54  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 771,671              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 80.26              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (113,207)              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 93.92              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (54,619)              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number         1,038,234   434,389  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares $ 92.91              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | $         $ 40,387      
2020 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares         $ 130.61      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 215,899              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 110.28 $ 129.25 $ 142.90          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number         1,359,242      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 134.98              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | $     $ 78,951   $ 52,875   $ 125,616  
Maximum [Member] | 2020 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Shares Authorized for Grants         3,500,000      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 250.00%              
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant         3,398,105      
Minimum [Member] | 2020 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 0.00%